Membrane organization of virus and target cell plays a role in HIV entry

Biochimie

Volumn 107, Issue Part A, 2014, Pages 22-27

  Dumas, Fabrice ^a,b   Preira, Pascal ^a   Salomé, Laurence ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

HIV; Lipids; Membrane dynamics

Indexed keywords

CD4 ANTIGEN RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; RECEPTOR; UNCLASSIFIED DRUG; CCR5 PROTEIN, HUMAN; CD4 ANTIGEN; GLYCOPROTEIN GP 120; GP120 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; PROTEIN BINDING;

CONFORMATIONAL TRANSITION; ENDOCYTOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MEMBRANE STRUCTURE; NONHUMAN; RECEPTOR BINDING; SHORT SURVEY; TARGET CELL; VIRUS ENTRY; BIOLOGICAL MODEL; CELL MEMBRANE; CHEMISTRY; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PHYSIOLOGY; VIROLOGY;

ANTIGENS, CD4; CELL MEMBRANE; HIV ENVELOPE PROTEIN GP120; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; MODELS, BIOLOGICAL; PROTEIN BINDING; RECEPTORS, CCR5; VIRUS INTERNALIZATION;

EID: 84915827879     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2014.08.015     Document Type: Short Survey

References (92)

1. A.C. Saphire, M.D. Bobardt, Z. Zhang, G. David, P.A. Gallay, Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages, J. Virol. 75 (2001) 9187-9200.
2. S. Ugolini, I. Mondor, Q.J. Sattentau, HIV-1 attachment: another look, Trends Microbiol. 7 (1999) 144-149.
3. D. Kabat, S.L. Kozak, K. Wehrly, B. Chesebro, Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1, J. Virol. 68 (1994) 2570-2577.
4. S.L. Kozak, et al., CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1, J. Virol. 71 (1997) 873-882.
5. E.J. Platt, K. Wehrly, S.E. Kuhmann, B. Chesebro, D. Kabat, Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1, J. Virol. 72 (1998) 2855-2864.
6. F. Kazazi, J.M. Mathijs, P. Foley, A.L. Cunningham, Variations in CD4 expression by human monocytes and macrophages and their relationships to infection with the human immunodeficiency virus, J. Gen. Virol. 70 (Pt 10) (1989) 2661-2672.
7. S.A. Mariani, E. Vicenzi, G. Poli, Asymmetric HIV-1 co-receptor use and replication in CD4(+) T lymphocytes, J. Transl. Med. 9 (Suppl. 1) (2011) S8.
8. L.A. Bagatolli, O.G. Mouritsen, Is the fluid mosaic (and the accompanying raft hypothesis) a suitable model to describe fundamental features of biological membranes? What may be missing? Front. Plant Sci. 4 (2013) 457.
9. D.M. Engelman, Membranes are more mosaic than fluid, Nature 438 (2005) 578-580.
10. F. Dumas, M.C. Lebrun, J.F. Tocanne, Is the protein/lipid hydrophobic matching principle relevant to membrane organization and functions? FEBS Lett. 458 (1999) 271-277.
11. A.M. Baker, et al., CD4 interacts constitutively with multiple CCR5 at the plasma membrane of living cells. A fluorescence recovery after photobleaching at variable radii approach, J. Biol. Chem. 282 (2007) 35163-35168.
12. P. Mascalchi, A.S. Lamort, L. Salomé, F. Dumas, Single particle tracking reveals two distinct environments for CD4 receptors at the surface of living T lymphocytes, Biochem. Biophys. Res. Commun. 417 (2012) 409-413.
13. I.I. Singer, et al., CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells, J. Virol. 75 (2001) 3779-3790.
14. Y. Percherancier, et al., HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains, J. Biol. Chem. 278 (2003) 3153-3161.
15. D. Lingwood, K. Simons, Lipid rafts as a membrane-organizing principle, Science 327 (2010) 46-50.
16. L.J. Pike, Rafts defined: a report on the keystone symposium on lipid rafts and cell function, J. Lipid Res. 47 (2006) 1597-1598.
17. K. Simons, E. Ikonen, Functional rafts in cell membranes, Nature 387 (1997) 569-572.
18. M.S. Freitas, et al., Measuring the strength of interaction between the ebola fusion peptide and lipid rafts: implications for membrane fusion and virus infection, PLoS One 6 (2011) e15756.
19. F.C. Bender, et al., Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry, J. Virol. 77 (2003) 9542-9552.
20. T. Gianni, V. Gatta, G. Campadelli-Fiume, {alpha}V{beta}3-integrin routes herpes simplex virus to an entry pathway dependent on cholesterol-rich lipid rafts and dynamin2, Proc. Natl. Acad. Sci. U. S. A. 107 (2010) 22260-22265.
21. K.S. Choi, H. Aizaki, M.M.C. Lai, Murine coronavirus requires lipid rafts for virus entry and cell-cell fusion but not for virus release, J. Virol. 79 (2005) 9862-9871.
22. S.L. Kozak, J.M. Heard, D. Kabat, Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus, J. Virol. 76 (2002) 1802-1815.
23. Z. Liao, L.M. Cimakasky, R. Hampton, D.H. Nguyen, J.E. Hildreth, Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1, AIDS Res. Hum. Retroviruses 17 (2001) 1009-1019.
24. W. Popik, T.M. Alce, W.C. Au, Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells, J. Virol. 76 (2002) 4709-4722.
25. P. Hug, et al., Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5, J. Virol. 74 (2000) 6377-6385.
26. G. Del Real, et al., Blocking of HIV-1 infection by targeting CD4 to nonraft membrane domains, J. Exp. Med. 196 (2002) 293-301.
27. W. Popik, T.M. Alce, CD4 receptor localized to non-raft membrane microdomains supports HIV-1 entry identification of a novel raft localization marker in CD4, J. Biol. Chem. 279 (2004) 704-712.
28. S.S. Rawat, et al., Restricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusion, Mol. Membr. Biol. 25 (2008) 83-94.
29. M.J. Lehmann, N.M. Sherer, C.B. Marks, M. Pypaert, W. Mothes, Actin- and myosin-driven movement of viruses along filopodia precedes their entry into cells, J. Cell. Biol. 170 (2005) 317-325.
30. E.A. Berger, et al., A new classification for HIV-1, Nature 391 (1998) 240.
31. Z. Lu, et al., Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains, Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 6426-6431.
32. C. Verhofstede, M. Nijhuis, L. Vandekerckhove, Correlation of coreceptor usage and disease progression, Curr. Opin. HIV AIDS 7 (2012) 432-439.
33. S.E. Kuhmann, E.J. Platt, S.L. Kozak, D. Kabat, Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1, J. Virol. 74 (2000) 7005-7015.
34. S.P. Layne, M.J. Merges, M. Dembo, J.L. Spouge, P.L. Nara, HIV requires multiple gp120 molecules for CD4-mediated infection, Nature 346 (1990) 277-279.
35. S.N. Mulampaka, N.M. Dixit, Estimating the threshold surface density of Gp120-CCR5 complexes necessary for HIV-1 envelope-mediated cell-cell fusion, PLoS One 6 (2011) e19941.
36. R. Sougrat, et al., Electron tomography of the contact between T cells and SIV/HIV-1: implications for viral entry, PLoS Pathog. 3 (2007) e63.
37. M.I. Chang, P. Panorchan, T.M. Dobrowsky, Y. Tseng, D. Wirtz, Single-Molecule analysis of human immunodeficiency virus type 1 gp120-receptor interactions in living cells, J. Virol. 79 (2005) 14748-14755.
38. T.M. Dobrowsky, Y. Zhou, S.X. Sun, R.F. Siliciano, D. Wirtz, Monitoring early fusion dynamics of human immunodeficiency virus type 1 at single-molecule resolution, J. Virol. 82 (2008) 7022-7033.
39. X. Xiao, et al., Constitutive cell surface association between CD4 and CCR5, Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 7496-7501.
40. S. Basmaciogullari, B. Pacheco, S. Bour, J. Sodroski, Specific interaction of CXCR4 with CD4 and CD8alpha: functional analysis of the CD4/CXCR4 interaction in the context of HIV-1 envelope glycoprotein-mediated membrane fusion, Virology 353 (2006) 52-67.
41. G. Gaibelet, et al., CD4 and CCR5 constitutively interact at the plasma membrane of living cells: a confocal fluorescence resonance energy transfer-based approach, J. Biol. Chem. 281 (2006) 37921-37929.
42. C.M. Steffens, T.J. Hope, Mobility of the human immunode ficiency virus (HIV) receptor CD4 and coreceptor CCR5 in living cells: implications for HIV fusion and entry events, J. Virol. 78 (2004) 9573-9578.
43. E. Vicenzi, P. Liò, G. Poli, The puzzling role of CXCR4 in human immunodeficiency virus infection, Theranostics 3 (2013) 18-25.
44. H. Kamiyama, et al., CXCR4-tropic, but not CCR5-tropic, human immunodeficiency virus infection is inhibited by the lipid raft-associated factors, acyclic retinoid analogs, and cholera toxin B subunit, AIDS Res. Hum. Retroviruses 29 (2013) 279-288.
45. H. Kamiyama, et al., Raft localization of CXCR4 is primarily required for X4-tropic human immunodeficiency virus type 1 infection, Virology 386 (2009) 23-31.
46. S. Lee, et al., Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1, J. Virol. 74 (2000) 5016-5023.
47. A.A. Nabatov, G. Pollakis, T. Linnemann, W.A. Paxton, M.P. de Baar, Statins Disrupt CCR5 and RANTES expression levels in CD4+ T lymphocytes in vitro and preferentially decrease infection of R5 versus X4 HIV-1, PLoS One 2 (2007).
48. G. Del Real, et al., Statins inhibit HIV-1 infection by down-regulating rho activity, J. Exp. Med. 200 (2004) 541-547.
49. S.H. Johnston, et al., A quantitative af finity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains, J. Virol. 83 (2009) 11016-11026.
50. K. Chikere, T. Chou, P.R. Gorry, B. Lee, Affinofile profiling: how efficiency of CD4/CCR5 usage impacts the biological and pathogenic phenotype of HIV, Virology 435 (2013) 81-91.
51. A.J. Flegler, G.C. Cianci, T.J. Hope, CCR5 conformations are dynamic and modulated by localization, trafficking and G Protein association, PLoS One 9 (2014).
52. D.C. Chan, D. Fass, J.M. Berger, P.S. Kim, Core structure of gp41 from the HIV envelope glycoprotein, Cell 89 (1997) 263-273.
53. W. Weissenhorn, A. Dessen, S.C. Harrison, J.J. Skehel, D.C. Wiley, Atomic structure of the ectodomain from HIV-1 gp41, Nature 387 (1997) 426-430.
54. R. Blumenthal, S. Durell, M. Viard, HIV entry and envelope glycoprotein-mediated fusion, J. Biol. Chem. 287 (2012) 40841-40849.
55. G.B. Melikyan, Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm, Retrovirology 5 (2008) 111.
56. A. Sáez-Cirión, et al., Sphingomyelin and cholesterol promote HIV-1 gp41 pretransmembrane sequence surface aggregation and membrane restructuring, J. Biol. Chem. 277 (2002) 21776-21785.
57. C. Magnus, R.R. Regoes, Analysis of the subunit stoichiometries in viral entry, PLoS One 7 (2012) e33441.
58. N. Vincent, C. Genin, E. Malvoisin, Identification of a conserved domain of the HIV-1 transmembrane protein gp41 which interacts with cholesteryl groups, Biochim. Biophys. Acta 1567 (2002) 157-164.
59. K. Salzwedel, J.T. West, E. Hunter, A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for env-mediated fusion and virus infectivity, J. Virol. 73 (1999) 2469-2480.
60. R.M. Epand, Cholesterol and the interaction of proteins with membrane domains, Prog. Lipid Res. 45 (2006) 279-294.
61. A.S. Veiga, M.A.R.B. Castanho, The influence of cholesterol on the interaction of HIV gp41 membrane proximal region-derived peptides with lipid bilayers, FEBS J. 274 (2007) 5096-5104.
62. A.L. Lai, J.H. Freed, HIV gp41 fusion peptide increases membrane ordering in a cholesterol-dependent fashion, Biophys. J. 106 (2014) 172-181.
63. A.L. Lai, A.E. Moorthy, Y. Li, L.K. Tamm, Fusion activity of HIV gp41 fusion domain is related to its secondary structure and depth of membrane insertion in a cholesterol-dependent fashion, J. Mol. Biol. 418 (2012) 3-15.
64. W. Qiang, Y. Sun, D.P. Weliky, A strong correlation between fusogenicity and membrane insertion depth of the HIV fusion peptide, Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 15314-15319.
65. L.V. Chernomordik, M.M. Kozlov, Mechanics of membrane fusion, Nat. Struct. Mol. Biol. 15 (2008) 675-683.
66. R. Chan, et al., Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides, J. Virol. 82 (2008) 11228-11238.
67. A. Ivankin, I. Kuzmenko, D. Gidalevitz, Cholesterol mediates membrane curvature during fusion events, Phys. Rev. Lett. 108 (2012) 238103.
68. F. Dumas, et al., Spatial regulation of membrane fusion controlled by modification of phosphoinositides, PLoS One 5 (2010) e12208.
69. C.M. Finnegan, et al., Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion, J. Virol. 81 (2007) 45294-45304.
70. M. De la Vega, et al., Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion, Retrovirology 8 (2011) 99.
71. G.B. Melikyan, HIV entry: a game of hide-and-fuse? Curr. Opin. Virol. 4 (2014) 1-7.
72. O.T. Fackler, B.M. Peterlin, Endocytic entry of HIV-1, Curr. Biol. 10 (2000) 1005-1008.
73. Y. Kubo, H. Hayashi, T. Matsuyama, H. Sato, N. Yamamoto, Retrovirus entry by endocytosis and cathepsin proteases, Adv. Virol. (2012) e640894.
74. K. Miyauchi, Y. Kim, O. Latinovic, V. Morozov, G.B. Melikyan, HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes, Cell 137 (2009) 433-444.
75. M. Permanyer, E. Ballana, J.A. Esté, Endocytosis of HIV: anything goes, Trends Microbiol. 18 (2010) 543-551.
76. C.B. Wilen, J.C. Tilton, R.W. Doms, HIV: cell binding and entry, Cold Spring Harb. Perspect. Med. 2 (2012) a006866.
77. G.C. Carter, L. Bernstone, D. Baskaran, W. James, HIV-1 infects macrophages by exploiting an endocytic route dependent on dynamin, Rac1 and Pak1, Virology 409 (2011) 234-250.
78. L.A. Gobeil, R. Lodge, M.J. Tremblay, Macropinocytosis-like HIV-1 internalization in macrophages is CCR5 dependent and leads to efficient but delayed degradation in endosomal compartments, J. Virol. 87 (2013) 735-745.
79. M. Bomsel, Transcytosis of infectious human immunodeficiency virus across tight human epithelial cell line barrier, Nat. Med. 3 (1997) 42-47.
80. V. Maréchal, et al., Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis, J. Virol. 75 (2001) 11166-11177.
81. L.A. Gobeil, R. Lodge, M.J. Tremblay, Differential HIV-1 endocytosis and susceptibility to virus infection in human macrophages correlate with cell activation status, J. Virol. 86 (2012) 10399-10407.
82. R.M. Markosyan, F.S. Cohen, G.B. Melikyan, Time-resolved imaging of HIV-env-mediated lipid and content mixing between a single virion and cell membrane, Mol. Biol. Cell. 16 (2005) 5502-5513.
83. G.C. Carter, et al., HIV entry in macrophages is dependent on intact lipid rafts, Virology 386 (2009) 192-202.
84. B. Van Wilgenburg, M.D. Moore, W.S. James, S.A. Cowley, The productive entry pathway of HIV-1 in macrophages is dependent on endocytosis through lipid rafts containing CD4, PLoS One 9 (2014) e86071.
85. S. Bhat, et al., The galactosyl ceramide/sulfatide receptor binding region HIV-1 gp120 maps to amino acids 206-275, AIDS Res. Hum. Retroviruses (1993) 175-181.
86. S.S. Rawat, B.T. Johnson, A. Puri, Sphingolipids: modulators of HIV-1 infection and pathogenesis, Biosci. Rep. 25 (2005) 329-343.
87. D. Hammache, et al., Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylceramide and ganglioside GM3, J. Biol. Chem. 273 (1998) 7967-7971.
88. Y.A. Klug, et al., Early and late HIV-1 membrane fusion events are impaired sphinganine lipidated peptides that target the fusion site, Biochem. J. 461 (2014) 213-222.
89. M. Lakadamyali, M.J. Rust, X. Zhuang, Endocytosis of influenza viruses, Microbes Infect. 6 (2004) 929-936.
90. M. Lakadamyali, M.J. Rust, H.P. Babcock, X. Zhuang, Visualizing infection individual influenza viruses, Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 9280-9285.
91. D.R. Morcock, et al., Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteins, J. Virol. 79 (2005) 1533-1542.
92. J.L. Rossio, et al., Inactivation of human immunodeficiency virus type infectivity with preservation of conformational and functional integrity virion surface proteins, J. Virol. 72 (1998) 7992-8001.